Disclosure Of Intangible Assets [Text Block]

ERYTECH Pharma S.A. - Filing #2810992

Concept 2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
Disclosure of intangible assets [text block]
Disclosure of detailed information about intangible assets [text block]
Disclosure of detailed information about intangible assets [abstract]
Disclosure of detailed information about intangible assets [line items]
Reconciliation of changes in intangible assets other than goodwill [abstract]
Intangible assets other than goodwill
21 362 EUR
5,000 EUR
15,000 EUR
Research and development expense
10 910 EUR
19 907 EUR
45 100 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.